LUPIN Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > lupin

Technical Analysis

Technical Strength: 2.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 29.7. According to RSI analysis, lupin is oversold. 7.0 LUPIN RSI Chart
MACD (?) MACD: -26.4 and Signal Line: -18.1. According to MACD analysis, lupin is technically weak. 2.0 LUPIN MACD Chart
Simple Moving Average (?) According to simple moving average analysis, lupin is in a strong downtrend. Major resistance levels are 1411.047, 1439.898, 1505.357. 0.0 LUPIN Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, lupin is in a strong downtrend. Major resistance levels are 1402.483, 1432.764, 1497.196. 0.0 LUPIN Exponential Moving Average Chart
Bollinger Bands (?) %b is -0.0118. According to bollinger bands, lupin has hit the lower band which is a negative signal. 1.0 LUPIN Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 1387.1926 and 1408.35. Support level is 1318.7. 2.5 LUPIN Fibonacci Retracement Chart
Average True Range (?) ATR: 27.2 NA LUPIN Average True Range Chart
Average Directional Index (?) ADX is 25.5 which means LUPIN is in a trend. NA LUPIN Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 28, 2017
Open Price 1340.0
High Price 1372.0
Low Price 1318.7
Close Price 1338.35
Absolute Change 2.15
Percentage Change 0.161%
Weekly Change -4.94%
Monthly Change -7.98%
Yearly Change -13.2%
52-week high 1750.0
52-week low 1318.7
Corporate Actions
ExDate Purpose
July 25, 2016 AGM/DIV-RS 7.50 PER SHARE
July 21, 2014 AGM/DIV-RS 3/- PER SHARE
February 13, 2014 INT DIV-RS 3/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.478
Confidence in Beta0.0846%
Market Capital Rs. 60250.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 63.72
TTM Price-to-Earnings (P/E) Ratio 21
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 28 April 2017: Deliverable Quantity:1.12e+06 NA LUPIN Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 28 April 2017: Daily Volatility:0.2522 NA LUPIN Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 28 April 2017: PCR_OI:0.569 PCR:0.229 NA LUPIN PCR Chart
Premium (?) 28 April 2017 Premium: 7.65 Futures OI:7854800.0 NA LUPIN Premium Chart
Option_MAX_OI (?) 28 April 2017: Price:1338.35 Put with maximum OI:1400.0 Call with maximum OI:1450.0 NA LUPIN Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
May 25, 2017 1346.0 7854800.0 9448.0 10396.0 1338.35
June 29, 2017 1353.5 80000.0 92.0 95.0 1338.35
July 27, 2017 1339.0 400.0 1.0 1.0 1338.35

Announcements

April 28, 2017 The ENews ClarificationExchange has sought clarification from the Company with respect to news item captioned "Lupin's Goa plant receives adverse FDA Observations". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
April 28, 2017 The ENews ClarificationExchange has sought clarification from the Company with respect to news item captioned "Lupin's Goa plant receives adverse FDA Observations". The response from the Company is enclosed.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 23, 2017 February 09, 2017 InterResultsr alia to consider and take on record the unaudited financial results for the quarter ended December 31, 2016
October 17, 2016 November 09, 2016 interResultsr alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016.
See all Board Meetings

LUPIN is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1261 Rs. 1290 Rs. 1314 Rs. 1343 Rs. 1367 Rs. 1396 Rs. 1421